SCHEMBL2764041

SCHEMBL2764041

[NH]CS(=O)(=O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2051129 0.71
SCHEMBL20084935 0.69
SCHEMBL2536810 0.69
SCHEMBL18332332 0.69
SCHEMBL19211566 0.69 LMNA (0.31)
SCHEMBL19211565 0.69 LMNA (0.31)
SCHEMBL2227276 0.69
SCHEMBL4430243 0.67
SCHEMBL22655810 0.65
SCHEMBL6893525 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176237-A1 PHTHALAZINONE DERIVATIVES AS INHIBITORS OF PARP-1 AstraZeneca AB (SE) 2010-04-21 EP disclosed
US-20090023727-A1 PHTHALAZINONE DERIVATIVES ASTRAZENECA UK LIMITED (GB) 2009-01-22 US disclosed
WO-2009004356-A1 PHTHALAZINONE DERIVATIVES AS INHIBITORS OF PARP-1 ASTRAZENECA AB (SE) 2009-01-08 WO disclosed